PODOFILOX

SynDRA canonical compound SYN0000318 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	IGF1R \| TOP2A \| TUBA4A \| TUBB
Mechanism of action	microtubule inhibitor \| tubulin polymerization inhibitor
Indication	genital warts
Disease area	infectious disease

All known targets

podophyllotoxin
condyline
Podophyllotoxin
NSC-24818
Condyline
Condylox
Warticon
Wartec
Podophyllotoxin 7
Podophyllinic acid lactone
(-)-Podophyllotoxin
Podofilox [USAN]
CCRIS 565
UNII-L36H50F353
Podophyllotoxin, 95%
HSDB 7238
NSC24818
CHEMBL61
EINECS 208-250-4
NSC 24818
(5R,5aR,8aR,9R)-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one
MLS000069495
AI3-50456
CHEBI:50305
Podofilox (USAN)
L36H50F353
Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one,
BRD-K47869605
Podophyllum
MFCD00075290
(10R,11R,15R,16R)-16-hydroxy-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-12-one
(5R,5aR,8aR,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one
(5R,5aR,8aR,9R)-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one
NCGC00022001-05
Podofilm
SMR000059121
(5R,5aR,8aR,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-8-one
(5R,5aR,8aR,9R)-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one